Dr.U.P.Rathnakar
Dr.U.P.Rathnakar
MD.DIH.PGDHM MD.DIH.PGDHM 1 1NSAIDs-II
NSAIDs-II
ARACHIDONIC ACID
ARACHIDONIC ACID
PGs
PGs
Cyclooxygenase-1
Cyclooxygenase-1
[Constitutive-Good???] [Constitutive-Good???]Cyclooxygenase-2
Cyclooxygenase-2
[Induced-Bad???] [Induced-Bad???]NSAIDs
NSAIDs
ADEs Uses ADEs Uses -Gastro protective -Gastro protective -Platelet function -Platelet function -Renal function -Renal function -Uterine contractions -Uterine contractions -Inflammation -Inflammation -Fever -Fever -Pain -Pain 2 2Classification-NSAIDs
Classification-NSAIDs
•
• Nonselective IrreversibleNonselective Irreversible
inhibitors of COX inhibitors of COX Aspirin
Aspirin
•
• Nonselective reversibleNonselective reversible
inhibitors of COX inhibitors of COX Ibuprofen, Diclofenac, Ibuprofen, Diclofenac, Indomethacin, Piroxicam Indomethacin, Piroxicam •
• Weak Weak inhibitors inhibitors of of COX1COX1
Nimesulide Nimesulide
•
• Preferential inhibitors ofPreferential inhibitors of
COX-2[>10times] COX-2[>10times] Meloxicam,Nabumetone, Meloxicam,Nabumetone, Etodolac Etodolac •
• Selective reversibleSelective reversible
inhibitors of COX-2[>50 inhibitors of COX-2[>50 times] times] Rofecoxib, Celecoxib, Rofecoxib, Celecoxib, Valdecoxib, Etoricoxib, Valdecoxib, Etoricoxib, Parecoxib Parecoxib •
• Inhibitors of COX-3[?]Inhibitors of COX-3[?]
or hypothalaamic COX-1 or hypothalaamic COX-1 inhibitors inhibitors Paracetaamol, Analgin Paracetaamol, Analgin •
• NSAIDsNSAIDs ––Not inhibitorsNot inhibitors
of COX of COX
Nefopam, Diacerein
NSAIDs-Common benefits and
NSAIDs-Common benefits and
ADEs
ADEs
Beneficial effects Beneficial effects •• AnalgesicAnalgesic •• Anti-inflammatoryAnti-inflammatory •• AntipyreticAntipyretic •• AntithromboticAntithrombotic•• Closure of D.A.-new bornClosure of D.A.-new born
Toxicities
Toxicities
•• Gastric ulcerGastric ulcer
•• GI bleedGI bleed
•• NephropathyNephropathy
•• Delay in labourDelay in labour
•• HypersensitivityHypersensitivity
•• Premature closure of D.A.Premature closure of D.A.
4 4
www.manipal.edu www.manipal.edu Albert Einstein, Albert Einstein, Wright Brothers Wright Brothers
John Logie Baird
John Logie Baird
“
A
A
spirin
spirin
[Acetylsalicylic acid]
[Acetylsalicylic acid]
•• The name aspirin is derived fromThe name aspirin is derived from “A”“A” fromfrom A
Acetyl andcetyl and “spirin”“spirin” from old German namefrom old German name Spirsaure
Spirsaure meaning salicylic acid.meaning salicylic acid.
•• Only drug which has lasted more than aOnly drug which has lasted more than a century! century! www.manipal.edu www.manipal.edu 1899 1899 2012 2012
Aspirin
Aspirin
•
• Chemically acetylsalicylic acidChemically acetylsalicylic acid •
• salicyclic acidsalicyclic acid •
• Nonselective, irreversiNonselective, irreversible inhibitor of ble inhibitor of COXCOX •
• Absorbed from stomach & Absorbed from stomach & small intestinessmall intestines •
• Poorly water solublePoorly water soluble –
– Microfining drug particles & adding alkaliMicrofining drug particles & adding alkali •
• Small vol of Small vol of distributidistribution; 80% on; 80% plasma proteinplasma protein
bound
bound •
• Metabolized in liver by glycine & glucuronic acidMetabolized in liver by glycine & glucuronic acid
conjugation conjugation Gut Gut wall, wall, liver, liver, plasma plasma 7 7 ⇛⇧ ⇛⇧absorptionabsorption
Pharmacological actions
Pharmacological actions
•
•
Analgesic:
Analgesic:
Relieves inflammatory, tissue injury related,
Relieves inflammatory, tissue injury related,
connective tissue & intugemental pain
connective tissue & intugemental pain
-- Ineffective in severe visceral & ischemic painIneffective in severe visceral & ischemic pain
--
Antipyretic:
Antipyretic:
-- Resets hypothalamic thermostatResets hypothalamic thermostat
And rapidly reduces fever by promoting heat
And rapidly reduces fever by promoting heat
loss
loss (sweating, (sweating, cutaneous cutaneous vasodilatation)vasodilatation)
–
–
Antiinflammatory:
Antiinflammatory:
–
– Suppresses signs of inflammation: pain,Suppresses signs of inflammation: pain,
8 8
Pharmacologic
Pharmacological
al actions
actions
[Aspirin]
[Aspirin]
––
Metabolic effects[high doses]:
Metabolic effects[high doses]:
–
– Cellular metabolism in skeletal musclesCellular metabolism in skeletal muscles heatheat production
production
–
– Utilization of glucoseUtilization of glucose blood sugar & liver glycogenblood sugar & liver glycogen is depleted
is depleted
•
• Toxic doses: hyperglycemiaToxic doses: hyperglycemia
–
– Central sympathetic stimulationCentral sympathetic stimulation
corticosteroids
corticosteroids
–
– Chronic useChronic use proteinprotein
9 9 ⇧⇛ ⇧⇛ ⇛⇩ ⇛⇩
release of adrenaline &
release of adrenaline & negative nitrogen balance
negative nitrogen balance⇛⇧⇛⇧
carbohydrate
•
•
Respiration:
Respiration:
–
– Anti-inflammatory dose: RespirationAnti-inflammatory dose: Respiration
stimulated
stimulated
•
• Peripheral:Peripheral: productionproduction
•
• Central:Central:
–
– Toxic doses-respiratory depressionToxic doses-respiratory depression
due to respiratory failure
due to respiratory failure
Pharmacologic
Pharmacological
al actions
actions
[Aspirin]
[Aspirin]
10 10 CO CO22sensitivity of respiratory centre to CO
sensitivity of respiratory centre to CO22
death
•
• Acid base & electrolyte balance:Acid base & electrolyte balance:
–
– Initially respiratory stimulationInitially respiratory stimulation wash out COwash out CO22
•
• Compensated by renal excretion of HCOCompensated by renal excretion of HCO33--(with accompanying(with accompanying
Na, K &
water)-Na, K & water)-Compensated resp.alkalosisCompensated resp.alkalosis
–
– Higher doses: respiratory depression with COHigher doses: respiratory depression with CO22 retention
retention
–
– Excess COExcess CO22 production continuesproduction continues acidosis
acidosis
Pharmacologic
Pharmacological
al actions
actions
Addition of dissociated Addition of dissociated salicylic acid +metabolic salicylic acid +metabolic acids- lactic, pyruvic acid acids- lactic, pyruvic acid
+ sulfuric & phosphoric + sulfuric & phosphoric
acids retained due to acids retained due to
Uncompensated Uncompensated metabolic acidosis metabolic acidosis 1 111 respiratory alkalosis respiratory alkalosis respiratory respiratory renal function renal function
Pharmacologic
Pharmacological
al actions
actions
[Aspirin][Aspirin]
•
•
CVS:
CVS:
–
–
Large doses:
Large doses:
meet
meet
22demand &
demand &
cause direct vasodilatation
cause direct vasodilatation
–
–
Toxic doses:
Toxic doses:
BP
BP
–
–
CHF may be precipitated
CHF may be precipitated
•
•
•
•
Retention of NA
Retention of NA
++& water [Renal
& water [Renal
insufficiency-COX inhibition]
insufficiency-COX inhibition]
1212cardiac output to
cardiac output to
peripheral O
peripheral O
vasomotor centre
vasomotor centre
⇛⇩⇛⇩Cardiac work
Cardiac work
Pharmacologic
Pharmacological
al actions
actions
[Aspirin][Aspirin]
•
•
Urate excretion:
Urate excretion:
•
•
Dose related effect
Dose related effect
–
–
< 2g/day: urate
< 2g/day: urate
retention[O
retention[O
pposes
pposes
uricosuric
uricosuric
drugs]
drugs]
–
–
2-5 g/day: variable effects
2-5 g/day: variable effects
–
–
> 5g/day: urate excretion
> 5g/day: urate excretion
13 13
•
•
GIT: Epigastric distress, nausea &
GIT: Epigastric distress, nausea &
vomiting-Irritant of mucosa
vomiting-Irritant of mucosa
Pharmacologi
Pharmacological cal actionsactions [Aspirin] [Aspirin] 14 14 Aspirin Aspirin [unionized] [unionized] Aspirin Aspirin [ionized] [ionized] Ion trapping Ion trapping
Acute ulcers, erosive gastritis, congestion microscopic hemorrhage Acute ulcers, erosive gastritis, congestion microscopic hemorrhage
••IrritantIrritant
••Ion trappingIon trapping
••Back diffusionBack diffusion of acid
of acid
••Inhibition ofInhibition of COX
•
•
Blood:
Blood:
–
–
Irreversible inhibition of Thromboxane
Irreversible inhibition of Thromboxane
(TXA
(TXA
22) synthesis by platelets
) synthesis by platelets
–
–
Interferes with platelet aggregation
Interferes with platelet aggregation
–
–
Prolongs bleeding time; lasts for a
Prolongs bleeding time; lasts for a
week.
week.
– –WHY?
WHY?
15 15Pharmacologic
Pharmacological
al actions
actions
[Aspirin]•
•
Low
Low
aspirin
aspirin
dose
dose
(50-150mg/day)
(50-150mg/day)
–
–
Platelets are exposed to aspirin in portal
Platelets are exposed to aspirin in portal
circulation before it undergoes first pass
circulation before it undergoes first pass
metabolism in liver
metabolism in liver
–
–
TXA2 irreversibly acetylated
TXA2 irreversibly acetylated
––
Platelets cannot synthesize fresh
Platelets cannot synthesize fresh
enzyme-No nucleus
enzyme-No nucleus
–
–
Inhibited for the life
Inhibited for the life
of platelets[7 days]of platelets[7 days]–
– But why administer low dose every day?But why administer low dose every day?
–
– New platelets are synthesized every dayNew platelets are synthesized every day
16 16
Pharmacologic
Pharmacological
al actions
actions
[Aspirin]•
•
At higher doses antiplatelet activity
At higher doses antiplatelet activity
is lost
is lost
–
–
At this dose aspirin also inhibits
At this dose aspirin also inhibits
prostacyclins[
prostacyclins[
PGI2
PGI2
] in the vessel wall
] in the vessel wall
which are potent antiplatelet agents
which are potent antiplatelet agents
–
–
Co-administration of other NSAIDs-
Co-administration of other
NSAIDs-this activity is lost
this activity is lost
1717Pharmacologic
Pharmacological
al actions
actions
[Low dose Aspirin]Adverse effects
Adverse effects
[Aspirin]
[Aspirin]
•
• Lower doses:Lower doses:
•
•
Nausea, vomiting, epigastric
Nausea, vomiting, epigastric
distress, increased occult
distress, increased occult
blood loss in stools.
blood loss in stools.
•
•
Most important adverse
Most important adverse
effect of aspirin is gastric
effect of aspirin is gastric
mucosal damage and peptic
mucosal damage and peptic
ulceration.
ulceration.
18 18
Adverse effects
Adverse effects
[Aspirin]
[Aspirin]
•
• Higher doses:Higher doses: •
• Salicylism-dizziness, tinnttus,Salicylism-dizziness, tinnttus, •
• vertigo, reversible impairment ofvertigo, reversible impairment of
hearing and vision, excitement and
hearing and vision, excitement and
mental confusion,hyperventilation
mental confusion,hyperventilation
and electrolyte imbalance.
and electrolyte imbalance.
•
• Dose gradually decreased tillDose gradually decreased till
tolerated
tolerated
•
• Hepatic damageHepatic damage
19 19
Adverse effects
Adverse effects
[Aspirin]
[Aspirin]
•
• Higher doses:Higher doses: •
• Metabolic toxicityMetabolic toxicity •
• 'Reye's syndrome', a rare form of'Reye's syndrome', a rare form of
hepatic encephalopathy
hepatic encephalopathy
•
• Aspirin+ children having viralAspirin+ children having viral
(varicella, influenza) infection
(varicella, influenza) infection
20 20
Adverse effects
Adverse effects
[Aspirin]
[Aspirin]
•
• Aspirin [Any NSAIDs] inducedAspirin [Any NSAIDs] induced
asthma
asthma
•
• Cross sensitivity-NSAIDsCross sensitivity-NSAIDs •
• Nimuselide-may be saferNimuselide-may be safer •
• Inhibition of PG synthesisInhibition of PG synthesis → More LT→ More LT
synthesis synthesis 21 21 PG PG
L
L
T
T
[Asthma][Asthma] COX pathwayAdverse effects
Adverse effects
[Aspirin]
[Aspirin]
•
• Hypersensitivity reactionsHypersensitivity reactions
22 22
Precautions & Contraindications
Precautions & Contraindications
[Aspirin]
[Aspirin]
•
• C/I: Sensitive, peptic ulcer, bleedingC/I: Sensitive, peptic ulcer, bleeding
tendencies, chicken pox or influenza suffering
tendencies, chicken pox or influenza suffering
children
children
•
• Any chronic liver diseaseAny chronic liver disease→Aspirin→→Aspirin→ hepatichepatic
necrosis
necrosis
•
• To be avoided in diabetics, low cardiac reserveTo be avoided in diabetics, low cardiac reserve
or frank CHF, juvenile rheumatoid arthritis
or frank CHF, juvenile rheumatoid arthritis
•
• Should be stopped 1 week before surgeryShould be stopped 1 week before surgery •
• To be avoided in pregnant, lactating & GTo be avoided in pregnant, lactating & G-6 PD-6 PD
deficiency
Drug interactions
Drug interactions
[Aspirin]
[Aspirin]
•
• Displacement reactions-Warfarin, sulfonylurea,Displacement reactions-Warfarin, sulfonylurea,
phenytoin
phenytoin
•
• Antagonizes uricosuric action-probenecidAntagonizes uricosuric action-probenecid •
• Blunts the action diuretics[Furosomide,thiazides]Blunts the action diuretics[Furosomide,thiazides]
24 24
Acute salicylate poisoning
Acute salicylate poisoning
Treatment:
Treatment:
•
•Symptomatic &Symptomatic &
supportive
supportive
•
•External coolingExternal cooling
[Hyperpyrexia!!!]; IV fluids
[Hyperpyrexia!!!]; IV fluids
with Na, K,HCO
with Na, K,HCO33 &&
glucose
glucose
•
•Alkaline diuresisAlkaline diuresis
•
•Gastric lavage;Gastric lavage;
•
•HaemodialysisHaemodialysis
•
•Blood transfusion &Blood transfusion & vitamin K
vitamin K
25 25
USES-ASPIRIN
USES-ASPIRIN
•
• Analgesic: headache, backache, myalgia, joint pain,Analgesic: headache, backache, myalgia, joint pain,
toothache, neuralgia & dysmenorrhoea toothache, neuralgia & dysmenorrhoea
•
• Antipyretic: fever of any originAntipyretic: fever of any origin
•
• Acute Rheumatic feverAcute Rheumatic fever
•
• Rheumatoid arthritisRheumatoid arthritis
•
• OsteoarthritisOsteoarthritis
•
• Postmyocardial infarction, post stroke patients,Postmyocardial infarction, post stroke patients,
TIA, DVT, Pulmonary embolism [Secondary
TIA, DVT, Pulmonary embolism [Secondary
prevention]
prevention]
•
• For closure of patent ductus arteriosusFor closure of patent ductus arteriosus
•
• ……….……….ContdContd….….
26 26
Uses
Uses
Aspirin
Aspirin
Other uses…
Other uses…
• • MastocytosisMastocytosis •• Familial Colonic polyposis [Prevention of recurrence]Familial Colonic polyposis [Prevention of recurrence]
•
• Prevention of colon & RECTAL cancerPrevention of colon & RECTAL cancer •
• Alzheimer’sAlzheimer’s
•
• PreeclampsiaPreeclampsia
•
• Niacin induced flushesNiacin induced flushes •
• Counter irritantCounter irritant
• • KeratolyticKeratolytic [Whitfield ointment] [Whitfield ointment] 27 27 •
•Analgesic: headache, backache, myalgia, jointAnalgesic: headache, backache, myalgia, joint
pain, toothache, neuralgia &
pain, toothache, neuralgia & dysmenorrhoedysmenorrhoeaa
•
•Antipyretic: fever of any originAntipyretic: fever of any origin
•
•Acute Rheumatic feverAcute Rheumatic fever
•
•Rheumatoid arthritisRheumatoid arthritis
•
•OsteoarthritisOsteoarthritis
•
•Postmyocardial infarction & post Postmyocardial infarction & post stroke patientsstroke patients
For closure of patent
Other salicylates
Other salicylates
•
• Methyl salicylate---Counter irritantMethyl salicylate---Counter irritant
•
• Salicylic acid….KeratolyticSalicylic acid….Keratolytic
•
• Salfasalazine---U.colitis & Rheumatoid arthritisSalfasalazine---U.colitis & Rheumatoid arthritis
•
• Sod. Salicylate-Anelgesic-not usedSod. Salicylate-Anelgesic-not used
28 28
osage osage [Aspirin] [Aspirin] • •
Lowdose- 50-150 mg
Lowdose- 50-150 mg
• •Medium[anelgesic&anti-pyretic] 300 to
Medium[anelgesic&anti-pyretic] 300 to
600mg 6-8 hourly
600mg 6-8 hourly
• •Large[Antiinflammatory]
Large[Antiinflammatory]
3-6 Grams/day
3-6 Grams/day
29 29www.manipal.edu